Initial Filing of Schedule 13G by Daniel Kaufman for Abeona Therapeutics Inc.

This Schedule 13G filing reports that Daniel Kaufman, a US citizen, beneficially owns 2,943,629 shares of Abeona Therapeutics Inc. common stock, representing 5.16% of the outstanding shares. This acquisition does not appear to be for the purpose of influencing the control of the company. The filing was made on March 27, 2026, with the event date of the transaction being March 26, 2026. Kaufman has sole voting and dispositive power over these shares. The principal executive offices of Abeona Therapeutics Inc. are located in Cleveland, OH.